title: Daytrana: the first year.
abstract: We investigated use of Daytrana in the first year post-launch in the US: May, 2006 through April, 2007. According to our data, a total of 512,085 prescriptions for Daytrana were written in the first year of launch; psychiatry accounted for 34 percent of these prescriptions. Children and adolescents represented 88 percent of Daytrana users as compared to only 57 percent for the broader ADHD market. Expert commentary describing these trends is provided.
authors.affiliation: Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia.
authors.forename: Elisa F
authors.initials: EF
authors.lastname: Cascade
authors.forename: Amir H
authors.initials: AH
authors.lastname: Kalali
authors.forename: David
authors.initials: D
authors.lastname: Feifel